drugset / Trial / NCT00805662
Nasal Oxcytocin During IUI
Completed
86 enrolled
Ludwig-Maximilians - University of Munich
Essex Pharma GmbH · collabOrganon GmbH (former name) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Placebo-controlled study. Application of nasal oxytocin (8 IU) during intrauterine insemination in 86 patients.
Timeline
- Start
- 2003-05
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 8 iu | Intranasal |